Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2955, abbreviated as LINC02955, is a gene transcribed into a long non-coding RNA molecule over 200 nucleotides in length that does not overlap known protein-coding genes[5]. LincRNAs broadly regulate gene expression at the chromatin and transcriptional level and may exert enhancer-like activity or help stabilize RNAs; their functions can be highly tissue-specific. Only a minority of lincRNAs have defined biological roles or are linked to disease states, and for LINC02955 specifically, current genomic and gene-centric databases do not report direct involvement in known cellular pathways, disease processes, or as drug targets[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2955 (LINC02955).